bioRxivNeurosciencePreprint
Physiological basis underlying antidepressant-induced activation of TrkB receptors
Okko AlitaloiD, Samuel KohtalaiD, Marko RosenholmiD, Piia KohtalaiD, Roosa SaarreharjuiD, Nobuaki MatsuiiD, Gemma González-HernándeziD, Heidi Kaastrup MülleriD, Wiebke TheilmanniD, Mirkka P. SarparantaiD, Anders Bue KleiniD, Olli K. KärkkäineniD, Stanislav V. RozoviD, Tomi RantamäkiiD
Abstract
We show that both pharmacological and non-pharmacological treatments of depression activate TrkB receptors--a well-established target of antidepressants--by inducing a physiological response coupled to sedation. Several rapid-acting antidepressants trigger TrkB signaling by evoking a state associated with electroencephalographic slow-wave activity, behavioral immobility, reduced cerebral glucose utilization, and lowered body temperature. Remarkably, antidepressant-induced TrkB signaling was not compromised in animals exhibiting reduced activity-dependent release of BDNF but was diminished by maintaining animals in warm ambient temperature. Most importantly, prevention of the hypothermic response attenuated the behavioral effects produced by rapid-acting antidepressant nitrous oxide. Our results suggest that the phenomenon underlying TrkB transactivation--changes in energy expenditure and thermoregulation--is essential, but not sufficient, for antidepressant responses. Indeed, regardless of differential clinical and pharmacodynamic properties, all drugs that disrupt energy metabolism and induce hypothermia activated TrkB. This study challenges pharmacology-centric hypotheses regarding antidepressant effects and highlight the role of complex changes in bioenergetics and thermoregulation. HighlightsO_LIRapid-acting antidepressants evoke homeostatic emergence of slow-wave sleep during which TrkB signaling becomes regulated. C_LIO_LINon-antidepressant metabolic inhibitors and diverse sedatives activate TrkB signaling. C_LIO_LIReduction in body temperature determined the ability of antidepressants to transactivate TrkB. C_LIO_LIDrug-induced TrkB signaling was blunted by maintenance of normothermic body temperature. C_LIO_LIWarm ambient temperature after nitrous oxide exposure blocked the antidepressant-like effects. C_LI Graphical abstract O_FIG O_LINKSMALLFIG WIDTH=200 HEIGHT=78 SRC="FIGDIR/small/458151v1_ufig1.gif" ALT="Figure 1"> View larger version (20K): org.highwire.dtl.DTLVardef@1f7351borg.highwire.dtl.DTLVardef@bf920forg.highwire.dtl.DTLVardef@10e34eaorg.highwire.dtl.DTLVardef@1b42bb6_HPS_FORMAT_FIGEXP M_FIG C_FIG
- Citations
- 0
Reproducibility ledger
Nobody has reported trying to reproduce this paper yet. Did you replicate an experiment or run the code? Your report saves the next lab a week.
Sign in to file a reproducibility report.
Related papers
- Putative rapid-acting antidepressant nitrous oxide ("laughing gas") evokes rebound emergence of slow EEG oscillations during which TrkB signaling is induced
S. Kohtala, W. Theilmann, … T. Rantamäki·Molecular NeurobiologyPeer-reviewed·Oct 4, 2018
- Antidepressant drugs act by directly binding to TRKB neurotrophin receptors
Plinio Cabrera Casarotto, Mykhailo Girych, … Eero Ċastrén·CellPeer-reviewed·Feb 18, 2021
- Isoflurane produces antidepressant effects and induces TrkB signaling in rodents
Hanna Antila, Maria Ryazantseva, … Tomi Rantamäki·Scientific ReportsPeer-reviewed·Aug 4, 2017
- Pharmacologically diverse antidepressant drugs disrupt the interaction of BDNF receptor TRKB and the endocytic adaptor AP-2
S. M. Fred, L. Laukkanen, … E. Castren·bioRxiv·Sep 30, 2019
- Antidepressant-like effect of losartan involves TRKB transactivation from angiotensin receptor type 2 (AGTR2) and recruitment of FYN
C. R. Alves Faria Diniz, P. Casarotto, … S. R. L. Joca·bioRxiv·Mar 13, 2018
- Effects of Repeated Treatment with Monoamine-Transporter-Inhibitor Antidepressants on Pain-Related Depression of Intracranial Self-Stimulation in Rats
S. S. Negus, L. Karim-Nejad, L. P. Legakis·bioRxiv·Sep 4, 2019